Showing results (61-70 of 77) with videos related to

Sort By:
Pageof 8
Arteriosclerosis, Thrombosis, and Vascular Biology|August 11, 2001
Human-derived anti-oxidized LDL autoantibody blocks uptake of oxidized LDL by macrophages and localizes to atherosclerotic lesions in vivoP X Shaw, S Hörkkö, S Tsimikas, et al.
The Journal of Clinical Investigation|October 1, 1989
Evidence for the presence of oxidatively modified low density lipoprotein in atherosclerotic lesions of rabbit and manS Ylä-Herttuala, W Palinski, M E Rosenfeld, et al.
Current Topics in Microbiology and Immunology|December 28, 2000
Neo-self antigens and the expansion of B-1 cells: lessons from atherosclerosis-prone miceG J Silverman, P X Shaw, L Luo, et al.
Lancet (London, England)|April 11, 1992
Autoantibody against oxidised LDL and progression of carotid atherosclerosisJ T Salonen, S Ylä-Herttuala, R Yamamoto, et al.
Arteriosclerosis (Dallas, Tex.)|May 1, 1990
Antisera and monoclonal antibodies specific for epitopes generated during oxidative modification of low density lipoproteinW Palinski, S Ylä-Herttuala, M E Rosenfeld, et al.
Arteriosclerosis, Thrombosis, and Vascular Biology|March 7, 2001
Troglitazone inhibits formation of early atherosclerotic lesions in diabetic and nondiabetic low density lipoprotein receptor-deficient miceA R Collins, W P Meehan, U Kintscher, et al.
Arteriosclerosis and Thrombosis : a Journal of Vascular Biology|September 1, 1993
Abundant expression of apoprotein E by macrophages in human and rabbit atherosclerotic lesionsM E Rosenfeld, S Butler, V A Ord, et al.
Arteriosclerosis, Thrombosis, and Vascular Biology|June 20, 1998
An animal model to study local oxidation of LDL and its biological effects in the arterial wallF Calara, P Dimayuga, A Niemann, et al.
Pageof 8